Acute Toxicities Comparison of Postoperative Chemoradiation Therapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase 3 Trial
机构:[1]Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China[2]Zhejiang Cancer Hospital, Hangzhou, China浙江省肿瘤医院[3]Cancer Hospital & Institute, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China[4]Guizhou Provincial Cancer Hospital, Guiyang, China[5]Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院放疗技术组医技科室[6]Peking University Third Hospital, Beijing, China[7]Beijing Hospital, Beijing, China[8]Department of oncology, The General Hospital of Chinese People‘s Armed Police, Beijing, China[9]Department of Radiation Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China[10]Cancer Hospital, Chinese Academy of Medical Science, Beijing, China[11]Zhejiang Provincial Cancer Hospital, Hangzhou, China浙江省肿瘤医院
第一作者机构:[1]Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
推荐引用方式(GB/T 7714):
Ren H.,Liu L.,Feng Y.,et al.Acute Toxicities Comparison of Postoperative Chemoradiation Therapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase 3 Trial[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2016,96(2):E172-E173.doi:10.1016/j.ijrobp.2016.06.1025.
APA:
Ren, H.,Liu, L.,Feng, Y.,Wang, W.,Wang, J....&Jin, J..(2016).Acute Toxicities Comparison of Postoperative Chemoradiation Therapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase 3 Trial.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,96,(2)
MLA:
Ren, H.,et al."Acute Toxicities Comparison of Postoperative Chemoradiation Therapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase 3 Trial".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 96..2(2016):E172-E173